MilliporeSigma  

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is dedicated to developing technologies and providing solutions to advance the success of gene therapies and innovators behind them. From media and reagents to viral purification and formulation, our range of specialized products can help you grow, purify, and formulate your gene therapy. As one of the first CDMOs to support the commercial production of gene therapies, we are ready to support the preclinical through commercial production of your therapeutic, with expertise in viral vector development & manufacturing , analytical development & product characterization, and viral clearance testing. Let's accelerate your manufacturing of viral vector-based therapies.